ArticleFrontiers in immunology2025
Global research hotspots and trends in microglia in ischemic stroke.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006-2025).Frontiers in immunology · 2026Pooled it
- Two decades of global research on tetanus vaccines and tetanus immunoglobulins: a comprehensive bibliometric analysis and integrative review (2000-2025).Frontiers in cellular and infection microbiology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study explores potential therapeutic strategies by analyzing the bibliometric analysis of microglia in ischemic stroke (IS) to identify the current status, hotspots, and trends in research. Methods: In this study, we visualized publications on IS and microglia indexed in the Web of Science Core Collection between January 1, 2010, and March 15, 2025, using VOSviewer and CiteSpace software. In addition, we optimized several visualization maps using Pajek and Scimago Graphica to present the analysis results more clearly and intuitively. Results: A total of 2,117 articles and reviews from 465 journals were included in the analysis. The number of publications reveals a steady increase over the years. China and the United States lead the field in terms of influence. Jun Chen from the University of Pittsburgh is the most influential scholar, and the Conclusion: This study uses bibliometric methods to summarize key findings in microglia-related IS research. The insights gained will provide valuable guidance and reference for developing new immunotherapeutic strategies based on microglia for more effective prevention and treatment of IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.